|
SLXNW Silexion Therapeutics Corp 2022416 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,733,000.00 |
| Balance Sheet |
|
Current Assets
|
$4,065,000.00 |
|
Assets
|
$4,602,000.00 |
|
Current Liabilities
|
$4,060,000.00 |
|
Liabilities
|
$4,311,000.00 |
|
Equity
|
$291,000.00 |
|
Shares Out
|
3126651.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,646,000.00 |
| Market Analysis |
Market Cap
|
$62,533.02 |
|
Price
|
$0.02 |
|
BVPS
|
0.09 |
|
PB
|
0.22 |
|
EPS
|
0.85 |
|
FCF
|
$-3,646,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:58 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:02 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLXNW documents filed with the SEC.
SLXNW Filings
Clear
